Infliximab Biosimilars in the Age of Personalized Medicine: Trends in Biotechnology
JAN: Japanese Accepted Names for Pharmaceuticals
FI139130 | 170277-31-3 | Infliximab | Biosynth
T3DB: Infliximab
PDF] Exploring the Binding Sites of Anti-Infliximab Antibodies in Pediatric Patients With Rheumatic Diseases Treated With Infliximab | Semantic Scholar
Molecular modeling of antibodies for the treatment of TNFα‐related immunological diseases - Pierri - 2016 - Pharmacology Research & Perspectives - Wiley Online Library